Abivax SA (ABVX)
NASDAQ: ABVX · IEX Real-Time Price · USD
-0.59 (-4.22%)
Jun 21, 2024, 4:30 PM EDT - Market closed

Abivax Market Cap

Abivax has a market cap or net worth of $843.09 million as of June 21, 2024.

Market Cap
Enterprise Value
1-Year Change
Stock Price

Market Cap Chart

Since October 20, 2023, Abivax's market cap has increased from $521.80M to $843.09M, an increase of 61.57%. That is a compound annual growth rate of 104.38%.


DateMarket Cap% Change
Jun 21, 2024843.20M-2.34%
Jun 20, 2024863.40M3.01%
Jun 18, 2024838.20M-1.70%
Jun 17, 2024852.70M-0.22%
Jun 14, 2024854.60M-0.29%
Jun 13, 2024857.10M-5.62%
Jun 12, 2024908.10M2.41%
Jun 11, 2024886.70M1.00%
Jun 10, 2024877.90M-2.41%
Jun 7, 2024899.60M2.47%
Jun 6, 2024877.90M3.11%
Jun 5, 2024851.40M1.50%
Jun 4, 2024838.80M-1.12%
Jun 3, 2024848.30M-3.71%
May 31, 2024881.00M4.94%
May 30, 2024839.50M1.68%
May 29, 2024825.60M-4.44%
May 28, 2024864.00M-0.94%
May 24, 2024872.20M-0.29%
May 23, 2024874.70M-2.80%
May 22, 2024899.90M-0.07%
May 21, 2024900.50M3.32%
May 20, 2024871.60M1.55%
May 17, 2024858.30M-2.58%
May 16, 2024881.00M0.35%
View and export this data all the way back to 2023. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Avanos Medical 876.31M
Centessa Pharmaceuticals 855.60M
Mesoblast 854.79M
Ocular Therapeutix 850.34M
HealthStream 838.98M
89bio 826.43M
Cogent Biosciences 812.71M
Perspective Therapeutics 804.25M
Market Cap Rankings